BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 28, 2016
View Archived Issues
Eisai and OMRF form research collaboration to study lupus
Read More
Prometic Life Sciences reports positive data in phase II/III trial of IV plasminogen
Read More
SBI signs license agreement with Neopharma for 5-ALA in diabetes and malaria
Read More
Dong-A ST and Beactica sign drug discovery collaboration and licensing agreement
Read More
Targeting oligosaccharyltransferase with novel compound shows promise against lung cancer cells
Read More
Adamas Pharmaceuticals submits NDA for ADS-5102
Read More
ProQR Therapeutics' study of QR-010 in CF meets primary endpoint
Read More
ChemoCentryx's CCX-168 leads to improvements in patient with C3 glomerulopathy
Read More
FDA places partial clinical hold on enrollment in durvalumab trials for head and neck cancer
Read More
Allergan exercises option to acquire Motus Therapeutics
Read More
Fluxion launches Spotlight 59 Oncology Panel
Read More
Janssen Research & Development announces launch of ACCELERATE registry for Castleman disease
Read More
First phase IIa trial of Medivir's MIV-711 fully enrolled, cleared to procede
Read More
Shanghai Huilun Life Science & Technology patents PARP-1 inhibitors
Read More
Gedeon Richter patents MCH1 receptor antagonists
Read More
Eisai reports FGFR-4 inhibitors for liver cancer
Read More
Dana-Farber Cancer Institute patent describes CDK inhibitors
Read More
Plexxikon divulges FLT3 mutant inhibitors for leukemia
Read More
Levo agrees terms with Ferring for worldwide rights to carbetocin for Prader-Willi syndrome
Read More
FDA approves Roche's Ventana PD-L1 assay as complementary diagnostic for atezolizumab in NSCLC
Read More
Cellid initiates phase I trial of BVAC-C for cervical cancer
Read More
Adaptimmune and MSD to evaluate Keytruda in combination with NY-ESO SPEAR in multiple myeloma
Read More
Alexion initiates registration trials for ALXN-1210 in PNH and aHUS
Read More
EMA accepts for review MAA for niraparib in ovarian cancer
Read More
Technische Universitaet Muenchen describes novel, selective PET tracer for alpha-synucleinopathies
Read More
Novel radiotracer from Avaant Pharmaceuticals may detect multidrug resistance
Read More
Novartis reports pipeline highlights of third quarter 2016
Read More
Chemotherapy enhances immunotherapy with ISA-101 in cervical cancer trial
Read More
Chugai recaps milestones of third quarter 2016
Read More
PD-L1 inhibitor atezolizumab successfully combined with MEK and BRAF inhibitors in melanoma trial
Read More